Mark Yarchoan

Johns Hopkins University

NIH Rank #5392
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#5,392
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 3 grants · National rank #5392.

Top grants by award amount

Mark Yarchoan's NIH grant portfolio, ranked by award amount.

  • 5R01CA265009-03R01
    Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
    $681.5K
    award amount
  • 1R01CA285544-01A1R01
    Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)
    $662K
    award amount
  • 1R01CA289041-01R01
    Exploiting A Critical Vulnerability To Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)
    $650.1K
    award amount

Affiliation

Institutions that have administered grants for Mark Yarchoan.

Affiliated with Johns Hopkins University (MD).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Johns Hopkins University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5392